Induction of cell death by stimulation of protein kinase C in human epithelial cells expressing a mutant ras oncogene: A potential therapeutic target

British Journal of Cancer

Volumn 78, Issue 5, 1998, Pages 641-651

  Hall Jackson, C A ^a   Jones, T ^b   Eccles, N G ^a   Dawson, T P ^a   Bond, J A ^a   Gescher, A ^b   Wynford Thomas, D ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Apoptosis; Epithelial cells; PKC; Ras

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; BISINDOLYLMALEIMIDE; DNA FRAGMENT; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

APOPTOSIS; ARTICLE; CHROMATIN CONDENSATION; CONTROLLED STUDY; DNA CLEAVAGE; ENZYME ACTIVATION; EPITHELIUM CELL; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN TRANSPORT;

EID: 0031927057     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.554     Document Type: Article

References (51)

1. Alessi DR, Cuenda A, Cohen P, Dudley DT and Saltiel AR (1995) PD-098059 is a specific inhibitor of the activation of mitogen activated protein kinase kinase in vitro and in vivo. J Biol Chem 270: 27489-27494
2. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N and Perucho M (1988) Most human carcinomas of the exocrine pancreas contain mutant c-k-ras genes. Cell 53: 549-554
3. Berra E, Diaz-Meco MT, Dominguez I, Municio MM, Sanz L, Lozano J, Chapkin RS and Moscat J (1993) Protein kinase C ζ isoform is critical for mitogenic signal transduction. Cell 74: 555-563.
4. Blumberg PM (1991) Complexities of the protein kinase C pathway. Mol Carcinogen 4: 339-344
5. Bond J, Dawson T, Lemoine N and Wynford-Thomas D (1992) Effect of serum growth factors and phorbol ester on growth and survival of human thyroid epithelial cells expressing mutant ras. Mol Carcinogen 5: 129-135
6. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boon JH, van der Eb AJ and Vogelstein B (1987) Prevalence of ras gene mutations in human colorectal cancers. Nature 327: 293-297
7. Cai H, Smola U, Wixler V, Eisenmann-Tape I, Diaz-Meco MT, Moscat J, Rapp and Cooper GM (1997) Role of diacylglycerol-regulated protein kinase C isotype in growth factor activation of the raf-1 protein kinase. Mol Cell Biol 17: 732-741
8. Chao T-S O, Foster DA, Rapp UR and Rosner MR (1994) Differential raf requirement for activation of mitogen-activated protein kinase by growth factors, phorbol esters and calcium. J Biol Chem 269: 7337-7341
9. Cohen GM, Sun X, Snowden RT, Dinsdale D and Skilleter DN (1992) Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem J 286: 331-334
10. Cohen P (1997) The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell Biol 7: 353-361
11. Compere SL, Baldacci PA, Sharpe AH and Jaenisch R (1989) Retroviral transduction of the human c-Ha-ras-1 oncogene into mid-gestation in mouse embryos promotes rapid epithelial hyperplasia. Mol Cell Biol 9: 6-14
12. Cowley S, Paterson H, Kemp P and Marshall CJ (1994) Activation of MAP kinase is necessary and sufficient for PC 12 differentiation and transformation of NIH 3T3 cells. Cell 77: 841-852
13. Dawson T, Bond J, Eccles N and Wynford-Thomas D (1993) Toxicity of phorbol esters for human epithelial cells expressing a mutant ras oncogene. Mol Carcinogen 8: 280-289
14. de Vente JE, Kukoly CA, Bryant WO, Posekany KJ, Chen J, Fletcher DJ, Parker PJ, Pettit GJ, Lozano G, Cook PP and Ways DK (1995) Phorbol esters induce death in MCF-7 breast cancer cells with altered expression of protein kinase C isoforms. J Clin Invest 96: 1874-1886
15. Dekker LV and Parker PJ (1994) Protein kinase C - a question of specificity. Trends Biochem Sci 19: 73-77
16. Droms KA and Malkinson AM (1991) Phorbol ester-induced tumour promotion by downregulation of protein kinase C. Mol Carcinogen 4: 1-2
17. Earnshaw WC (1995) Apoptosis: lessons from in vitro systems. Trends Cell Biol 5: 217-220
18. Franza BR, Maruyama K, Garrels JI and Ruley HE (1986) In vitro establishment is not a sufficient prerequisite for transformation by activated Ras oncogenes. Cell 44: 409-118
19. Fukasawa K and Vande Woude GF (1997) Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability. Mol Cell Biol 17: 506-518
20. Fukuda M, Gotoh Y and Nishida E (1997) Interaction of MAP kinase with MAP kinase kinase: its possible role in the control of nucleocytoplasmic transport of MAP kinase. EMBO J 15: 1901-1908
21. Gescher A (1992) Towards selective pharmacological modulation of protein kinase C - opportunities for the development of novel antineoplastic agents. Br J Cancer 66: 10-19
22. Grammer TC and Blenis J (1997) Evidence for MEK-independent pathways regulating the prolonged activation of the ERK-MAP kinases. Oncogene 14: 1635-1642
23. Greif H, Ben-Chaim J, Shimon T, Bechor E, Eldar H and Livine E (1992) The protein kinase C related PKC-L (η) gene product is localized in the cell nucleus. Mol Cell Biochem 12: 1304-1311
24. Hennings H, Blumberg PM, Pettit GR, Herald CL, Shores R and Yuspa SH (1987) Bryostatin 1, an activator of protein kinase C, inhibits tumour promotion by phorbol esters in SENCAR mouse skin. Carcinogenesis 8: 1343-1346
25. Hirakawa T and Ruley HE (1988) Rescue of cells from ras oncogene-induced grow th by arrest by a second, complementing, oncogene. Proc Natl Acad Sci USA 85: 1519-1523
26. Hornung RL, Pearson JW, Beckwith M and Longo DI (1993) Preclinical evaluation of bryostatin as an anticancer agent against several murine tumour cell lines: in vitro versus in vivo activity. Cancer Res 52: 101-107
27. Johnson NL, Gardner AM, Diener KM, Langecarter CA, Gleavy J, Jarpe MB, Minden A, Karin M, Zon LI and Johnson GL (1996) Signal transduction pathways regulated by mitogen-activated extracellular response kinase kinase kinase induce cell-death. J Biol Chem 271: 3229-3237
28. Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J and Evan G (1997) Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385: 544-548
29. Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H, Finkenzeller G, Marme D and Rapp UR (1993) Protein kinase C α activates RAF-1 by direct phosphorylation. Nature 364: 249-252
30. Lemoine NR, Mayall ES, Wyllie FS, Williams D, Goyns M, Stringer B and Wynford-Thomas D (1989) High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene 4: 159-164
31. Lin H-J, Eviner V, Prendergast GC and White E (1995) Activated H-ras rescues E1A-induced apoptosis and co-operates with E1A to overcome p53-dependent growth arrest. Mol Cell Biol 15: 4536-4544
32. Malcomson RDG, Oren M, Wyllie AH and Harrison DJ (1995) p53-independent death and p53-induced protection against apoptosis in fibroblasts treated with chemotherapeutic drugs. Br J Cancer 72: 952-957
33. Marquardt B, Frith D and Stabel S (1994) Signalling from TPA to MAP kinase requires protein kinase C, raf and MEK: reconstitution of the signalling pathway in vitro. Oncogene 9: 3213-3218
34. Marshall CJ (1996) Ras effectors. Current Biol 8: 197-204
35. Namba H, Rubin SA and Fagin JA (1990) Point mutations of ras oncogenes are an early event in thyroid tumorigenesis. Mol Endocrinol 4: 1474-1479
36. Ono Y, Fujii T, Ogita KT, Kikkawa K, Igarashi K and Nishizuka Y (1988) Protein kinase C ζ subspecies from rat brain: its structure expression and properties. Proc Natl Acad Sci USA 86: 3099-3103
37. Parker PJ, Bosca L, Dekker L, Goode NT, Hajibagheri N and Hansra G (1995) Protein kinase C (PKC)-induced PKC degradation: a model for downregulation. Biochem Soc Trans 23: 53-55
38. Philips PA, Rea D, Thavasu P, Carmichael J, Stuart NSA, Rockett H, Talbot DC, Ganesan T, Pettit GR, Balkwill F and Harris AL (1993) Phase 1 study of bryostatin 1: assessment of interleukin 6 and tumor necrosis factor α induction in vivo. J Natl Cancer Inst 85: 1812-1818
39. Prendiville J, Crowther D, Thatcher N, Woll PJ, Fox BW, McGown A, Testa N, Stern P, McDermott R, Potter M and Pettit GR (1993) A phase 1 study of bryostatin 1 in patients with advanced cancer. Br J Cancer 68: 414-424
40. Ridley AJ, Paterson HF, Noble M and Land H (1988) ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation. EMBO J 7: 1635-1645
41. Sambrook J, Fritsch EF and Maniatis T (1989) Molecular Cloning: A laboratory manual 2nd edn. New York: Cold Spring Harbor Laboratory Press
42. Schonwasser DC, Marais RM, Marshall CJ and Parker PJ (1998) Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel and atypical protein kinase C isotypes. Mol Cell Biol 18: 790-798
43. ink4a. Cell 88: 593-602
44. Stanwell C, Gescher A, Bradshaw TD and Pettit GR (1994) The role of protein kinase C isoenzymes in the growth and inhibition caused by bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cells. Int J Cancer 56: 585-592
45. Suarez HG, du Villard JA, Severino M, Caillou B, Schlumberger M, Tubiana M, Parmentier C and Monier R (1990) Presence of mutations of all three ras genes in human thyroid tumors. Oncogene 5: 565-570
46. Szallasi Z, Denning MF, Smith CB, Dlugosz AA, Yuspa SH, Pettit GR and Blumberg PM (1994) Bryostatin 1 protects protein kinase C-δ from downregulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation. Mol Pharmacol 46: 840-850
47. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Bandet V, Boissins P, Boursier E, Loriolle F, Duhamel L, Charons D and Kirilovsky J (1990) The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266: 15771-15781
48. Traverse S, Gomez N, Paterson H, Marshall C and Cohen P (1992) Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Biochem J 288: 351-355
49. Wang C, Constantinescu SN, MacEwan DJ, Strulovici B, Dekker LV, Parker PJ and Pfeffer LM (1993) Interferon α induces protein kinase C-ε (PKC-ε) gene expression and a 4.7-kb PKC ε related transcript. Proc Natl Acad Sci USA 90: 6944-6948
50. Williams DW, Wynford-Thomas D and Williams ED (1987) Control of human thyroid follicular cell proliferation in suspension and monolayer culture. Mol Cell Endocrinol 51: 33-40
51. Xia Z, Dickens M, Raingeaud J, Davis RJ and Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331